Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.

ABSTRACT:

SUBMITTER: VandeVrede L 

PROVIDER: S-EPMC10564667 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature